Longboard Pharmaceuticals Inc (LBPH) Opciones

Yup Their it is like I said got to see the angles before they are played! Unreal!

Now I get to buy some more beaten down bios for my kid.

Denmark's Lundbeck bets on epilepsy drug in $2.6 billion Longboard deal

1000% gains+ for the year here!

$LBPH

Time to take profits at $55 … Longboard shareholders will be offered a payment of USD 60.00 per share in cash. The transaction is valued at approximately USD 2.6 billion equity value and USD 2.5 billion (approximately DKK 17 billion) net of cash, on a fully diluted basis.

LBPH trending sideways again

https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri
https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation

MY best performing Bio this year! Surfs up Vertical debit spreads from $5.00 are up over 1430% wish i went heavier keep an eye on ICCM

$LBPH

#LBPH 🔥 short squeeze might push this way higher! Nice set up!

Insane … grats all

LOTTO Ticket for 2024: Curative Biotechnology $CUBT @ $0.02 is a biotech with some very promising technology in the treatment of Age-Related Macular Degeneration (AMD). Metformin, a widely used diabetes drug, has been proven to have positive effects on patients with AMD. CUBT has a patented formulation for the direct delivery of metformin to the eye in the form of eye drops. The National Institutes of Health (NIH) will be funding a clinical trial on humans in 2024 in collaboration with the company. There has been a number of delays in the start of the trials, hence the low price, but the price has been firming up this past month. Although difficult to predict when these announcements happen, at these prices, CUBT is worth buying a small position (you can define "small") to make certain you are following the news and the price reaction so you can average up on your original position. Check the CUBT website out to see more info on the trials and the company's other drugs in the pipeline. Target Price by end of First Quarter (assuming clinical trial announcement)--$0.15).

SOURCE: https://www.reddit.com/r/pennystocks/comments/18uvm1j/trading_ideas_for_january_sing_migi_cubtmentioned/

It should go without saying, BUT some may need to read it...the above is someone's opinion. Nice to see anyways.

Congrats on being a quick thinker. Per-market buying can be risky, but does pan out.

The company has 9.5 months of cash left based on quarterly cash burn of -$13.28M and estimated current cash of $42.0M.
https://dilutiontracker.com/app/search/LBPH?a=dbb88c

AVTX Data Due on Watch here after 1 for 240 RS micro Float

Grabbed some at 8am immediately following news.
Looking good moving into open.
Sold half on double. Riding rest free.
What a way to start 2024!

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

An epileptic profit nice…

My First Almost 200% Profit (Within One Hour) In 2024 ... :)))))))))))))

In @ 6.25
Out @ 17.95

LBPH